Janssens Specs

Listing Results Janssens Specs

About 18 results and 4 answers.

Janssen COVID-19 Vaccine

Based on an updated risk-benefit analysis, use of mRNA COVID-19 vaccines is preferred over the Janssen COVID-19 Vaccine for all vaccine-eligible people ages 18 years or older for the primary series and booster dose. Start the two-dose mRNA COVID-19 vaccine series, even if there is uncertainty about how the patient will receive their second dose.

In some cases, you may administer Janssen COVID-19 to patients ages 18 years  and older:

  • When there is a contraindication to mRNA COVID-19 vaccines (e.g., severe allergic reaction after a previous dose or to a component of an mRNA COVID-19 vaccine)
  • When a person would otherwise remain unvaccinated for COVID-19 due to limited access to mRNA COVID-19 vaccines.
  • When a person wants to receive the Janssen COVID-19 Vaccine despite the safety concerns identified

    In these situations, inform patients about the: